ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)
Shujuan Pan(Baylor College of Medicine), Richard N. Sifers(Baylor College of Medicine)
Cited by 21
Related Papers
Ginsenoside Rh2 Alleviates LPS-Induced Inflammatory Responses by Binding to TLR4/MD-2 and Blocking TLR4 Dimerization
|International Journal of Molecular Sciences|2024|9